JohnBCopleyMD

PubMed

• Cost-Minimization Analysis of Lanthanum Carbonate Versus Sevelamer Hydrochloride in US Patients With End-stage Renal Disease.
  Keith, M. S.,Wilson, R. J.,Preston, P.,Copley, J. B.> ;Clin Ther. 2014 Jul 30
• Dietary trends and management of hyperphosphatemia among patients with chronic kidney disease: an international survey of renal care professionals.
  Fouque, D.,Casal, M. C.,Lindley, E.,Rogers, S.,Pancířová, J.,Kernc, J.,Copley, J. B.> ;J Ren Nutr. 2014 Jan 23
• Dose relativity of sevelamer hydrochloride and lanthanum carbonate under real-world conditions: Implications for management of patients with end-stage renal disease an...
  Copley, J. B.,Wilson, R. J.,Keith, M. S.> ;Value Health. 2013 May 23
• A real-world economic analysis of the cost implications of switching from sevelamer hydrochloride to lanthanum carbonate in the bundled reimbursement scheme.
  Keith, M. S.,Wilson, R. J.,Copley, J. B.> ;Value Health. 2013 May 23
• 32 citations
  Therapeutic management of post-kidney transplant hyperparathyroidism.
  John B. Copley, Rudolf P. Wüthrich> ;Clinical Transplantation. 2011 Jan 1
• 15 citations
  Longitudinal study of bone mass in end-stage renal disease patients: effects of parathyroidectomy for renal osteodystrophy.
  John B. Copley, Siu L. Hui, Stephen B. Leapman, Charles W. Slemenda, C. Conrad Johnston> ;Journal of Bone and Mineral Research. 2009 Dec 3
• Optimizing hypertension control in patients with multiple cardiovascular risk factors.
  John B. Copley> ;Journal of Clinical Hypertension. 2006 Oct 1
• 79 citations
  Beneficial effects of the bioflavonoids curcumin and quercetin on early function in cadaveric renal transplantation: a randomized placebo controlled trial.
  Daniel A. Shoskes, Chantale Lapierre, Marcia Cruz-Corerra, Nicolas Muruve, Reinaldo Rosario, Beth Fromkin, Mauro Braun, John B. Copley> ;Transplantation. 2005 Dec 15
• 5 citations
  Hypertension: a review and rationale of treatment.
  John B. Copley, Reinaldo Rosario> ;Disease-a-Month. 2005 Oct 1
• 18 citations
  Renal fibromuscular dysplasia in elderly persons.
  Amaryllis Pascual, Howard S. Bush, John B. Copley> ;American Journal of Kidney Diseases. 2005 Apr 1
• 19 citations
  Renal failure, glomerulonephritis and morbid obesity: improvement after rapid weight loss following laparoscopic gastric bypass.
  Flavia Soto, Guillermo Higa-Sansone, John B Copley, Mariana Berho, Colleen Kennedy, Emanuelle LoMenzo, David Podkameni, Samuel Szomstein, Raul J. Rosenthal> ;Obesity Surgery. 2005 Jan 1
• 4 citations
  Phase I study of oral bioflavonoids in cadaveric renal transplant recipients: effects on delayed graft function and calcineurin inhibitor toxicities.
  Daniel A. Shoskes, M. Thomas, R. Pobgee, Beth Fromkin, John B. Copley> ;Transplantation Proceedings. 2003 Mar 1
• A 26-year-old man with kidney alloraft failure and foot pain
  Monica P. Revelo, Catherine Staffeld, John B. Copley, Agnes B. Fogo> ;American Journal of Kidney Diseases. 2001 Apr 1
• 4 citations
  Xanthogranulomatous pyelonephritis in a renal allograft recipient
  Harriette M. Scarpero, John B. Copley> ;American Journal of Kidney Diseases. 1997 Dec 1
• 7 citations
  Effect of citrate on serum aluminum concentrations in hemodialysis patients: a prospective study.
  Lindberg Js, John B. Copley, Koenig Kg, Cushner Hm> ;Southern Medical Journal. 1993 Dec 1
• 3 citations
  Calcium citrate without aluminum antacids does not cause aluminum retention in patients with functioning kidneys
  Khashayar Sakhaee, Cindy L. Wabner, Joseph E. Zerwekh, John B. Copley, Laura Pak, John R. Poindexter, Charles Y.C. Pak> ;Bone and Mineral. 1993 Jan 1
• 72 citations
  Free and total 1,25-dihydroxyvitamin D levels in subjects with renal disease.
  Karl G. Koenig, Jill S. Lindberg, Joseph E. Zerwekh, Paulette Padalino, Howard M. Cushner, John B. Copley> ;Kidney International. 1992 Jan 1
• 11 citations
  Soft Tissue Calcification in Renal Failure
  Robin L. Southwood, Bruce A. Mueller, John B. Copley> ;DICP. 1990 Sep 1
• 31 citations
  Calcium citrate, a nonaluminum-containing phosphate-binding agent for treatment of CRF
  H.M. Cushner, John B. Copley, Jill S. Lindberg, Charles J. Foulks> ;Kidney International. 1988 Jan 1
• 30 citations
  Prevention of Peritoneal Dialysis Catheter-Related Infections
  John B. Copley> ;American Journal of Kidney Diseases. 1987 Dec 1
• 139 citations
  The quality of life of hemodialysis and transplant patients
  John P. Johnson, Clark McCauley, John B. Copley> ;Kidney International. 1982 Sep 1
• Analysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients.
  Farrand, K. F.,Copley, J. B.,Heise, J.,Fridman, M.,Keith, M. S.,Poole, L.> ;Int J Nephrol Renovasc Dis. 2014 Jul 22
• Renal failure with minimal change nephrotic syndrome: reversal with hemodialysis.
  Sjoberg, R. J., McMillan, V. M., Bartram, L. S., Copley, J. B.> ;Clin Nephrol. 1983 Aug
• Prospective comparison of peritoneoscopic and surgical implantation of CAPD catheters.
  Pastan, S., Gassensmith, C., Manatunga, A. K., Copley, J. B., Smith, E. J., Hamburger, R. J.> ;ASAIO Trans. 1991 Jul 01
• Utility of skin biopsy in the diagnosis of IgA nephropathy.
  Hasbargen, J. A., Copley, J. B.> ;Am J Kidney Dis. 1985 Aug 01
• Join now to see all